News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Xillix Technologies (CT:XLX) Announces Third Quarter Financial Results



10/27/2005 2:11:24 PM

Xillix Technologies Corp. (TSX:XLX), the world leader in fluorescence endoscopy for the early detection of cancer, today announced results for the third quarter ended September 30, 2005. The Company also outlined plans for a multi-center clinical trial in colon cancer with its latest device, Onco-LIFETM, which was recently approved by the U.S. Food and Drug Administration (FDA) for use in the detection of lung cancer, the leading cause of cancer death in both men and women.

Read at CCNMatthews


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES